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Mutations of cystic ﬁbrosis (CF) transmembrane conductance regulator (CFTR) cause
lethal hereditary disease CF that involves extensive destruction and dysfunction of serous
epithelium. Possible pharmacological therapy includes correction of defective intracellu-
lar processing and abnormal channel gating. In a previous study, we identiﬁed ﬁve natural
coumarin potentiators of ΔF508-CFTR including osthole, imperatorin, isopsoralen, praerup-
torin A, and scoparone.The present study was designed to determine the activity of these
coumarine compounds on CFTR activity in animal tissues as a primary evaluation of their
therapeutic potential. In the present study, we analyzed the afﬁnity of these coumarin
potentiators in activating wild-type CFTR and found that they are all potent activators.
Osthole showed the highest afﬁnity with K d values <50 nmol/L as determined by Ussing
chamber short-circuit current assay. Stimulation of rat colonic mucosal secretion by osthole
was tested by the Ussing chamber short-circuit current assay. Osthole reached maximal
activation of colonic Cl− secretion at 5μmol/L. Stimulation of mouse tracheal mucosal
secretion was analyzed by optical measurement of single gland secretion. Fluid secretion
rate of tracheal single submucosal gland stimulated by osthole at 10μmol/L was three-fold
more rapid than that in negative control. In both cases the stimulated secretions were fully
abolished by CFTRinh-172. In conclusion, the effective stimulation of Cl– and ﬂuid secretion
in colonic and tracheal mucosa by osthole suggested the therapeutic potential of natural
coumarin compounds for the treatment of CF and other CFTR-related diseases.
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INTRODUCTION
Cystic ﬁbrosis (CF) transmembrane conductance regulator
(CFTR) is a multidomain glycoprotein, belongs to the adenine
nucleotide-binding cassette (ABC) transporter family (Kerem
et al., 1989), and is the only anion channel of ABC superfam-
ily (He et al., 2008). CFTR is extensively expressed on the luminal
surface of serous epithelial cellsmost prominently in the intestines,
airways, pancreas, bile ducts, epididymis, and conjunctiva (Kun-
zelmann, 1999; Hanrahan and Wioland, 2004; Riordan, 2008). It
has been conﬁrmed that CFTR play a vital role in the absorption
and secretion of electrolytes and ﬂuid in submucosal glands (Kun-
zelmann, 1999; Thiagarajah and Verkman, 2003; Riordan, 2008).
In some epithelia such as in colon, CFTR may account for the
entire apical chloride conductance (Greger, 2000). Besides as a
cAMP-dependent chloride channel, CFTR also regulates activi-
ties of other ion channels, such as the epithelial Na+ channel
(ENaC; Berdiev et al., 2009), outwardly rectifying Cl− channel
(ORCC; Jovov et al., 1995; Hryciw and Guggino, 2000), KvLQT1
(Boucherot et al., 2001), ROMK (Ho, 1998), and water channel
(Castro-Parodi et al., 2009). In addition, CFTR may play roles
in establishing the low pH in the biosynthetic compartments
of the trans-Golgi network and in endosomes (Machen et al.,
2001).
Altered function of CFTR is related to many clinical symp-
toms. For example, mutations in CFTR that alters its biogenesis
and/or intrinsic transport function cause the hereditary lethal
disease CF (Marcet and Boeynaems, 2006). On the other hand,
improper activation of CFTR is involved in diseases such as sec-
retary diarrhea (Thiagarajah and Verkman, 2003) and polycystic
kidney disease (PKD; Li and Sheppard, 2009). Altered CFTR func-
tion also accounts for curtain other disorders, such as constipation
(Pratha et al., 2000), keratoconjunctivitis sicca (KCS; Levin and
Verkman, 2005), and idiopathic chronic pancreatitis (ICP; Cohn
et al., 1998). Therefore, CFTR became a potential drug target for
these diseases.
In a previous study, we identiﬁed a family of natural coumarin
compounds that can potentiate Cl– transport through ΔF508-
CFTR by screening a collection of 386 natural single compounds
from Chinese medicinal herbs (Xu et al., 2008). However, the
in vivo effects of these coumarin compounds have not been deter-
mined. In the present study, we ﬁrst characterized the activity of
these coumarin ΔF508-CFTR potentiators on wild-type CFTR
(wt-CFTR) and then examined their effect on Cl– secretion in
freshly isolated rodent colonic and tracheal mucosa. The results
indicated effective stimulation of Cl– secretion in live tissues and
therefore support the therapeutic potential of coumarin CFTR
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potentiators for CFTR-related diseases including CF, constipation,
and ICP.
MATERIALS AND METHODS
COUMARINS
Coumarins were purchased from the National Institute for the
Control of Pharmaceutical and Biological Products in China
(purity >99%). The purities of compounds were conﬁrmed by
HPLC/MS analysis. Compounds were dissolved inDMSO tomake
a 20-mmol/L stock solution. In all tests, Cells were exposed to a
ﬁnal concentration of DMSO of <1%, to avoid DMSO effects on
the cell-based assay.
CELL LINES
Halide-sensitive yellow ﬂuorescent protein mutant (EYFP-
H148Q) and human wt-CFTR cotransfected ﬁscher rat thyroid
(FRT) epithelium were generated and cultured as references
(Galietta et al., 2001; Yang et al., 2003). The cells were prepared
both for ﬂuorescence functional and electrophysiological analy-
ses. For ﬂuorescence assay, FRT cells were plated into a special
black-walled, clear-bottomed 96-well tissue culture plate (Costar,
Corning, NY, USA), and incubated at 37˚C for 24 h before mea-
surement of compound activity. For the electrophysiological Uss-
ing chamber assay, cells were cultured on the porous supports
Snapwell inserts (Costar, Corning, NY, USA) at 37˚C for 7 days
before measurements.
FLUORESCENCE ASSAY OF CFTR CHANNEL FUNCTION
Fischer rat thyroid cells grown in 96-well tissue culture plates were
washed three times with phosphate-buffered saline (PBS), then
incubated with 100 nmol/L forskolin without (control) or with
coumarin in a ﬁnal volume of 40μl for 10min. The ﬂuorescence
of each well was recorded for 14 s (ﬁve points per second) con-
tinuously in a ﬂuorescence plate reader (FLUOstar Optima; BMG
Laboratory Technologies, Offenburg, Germany) with 2 s before
and 12 s after injection of 120μl of and I−-containing solution
(PBS with 137mMCl− replaced by equal concentration of I−). I−
inﬂux rates (d[I−]/dt at t = 0) were computed from ﬂuorescence
time course data by single exponential regression, as described
previously (Ma et al., 2002).
ELECTROPHYSIOLOGY
Transepithelial Cl− current were measured on both CFTR trans-
fected FRT cells and rat mucosa. FRT cells were cultured on
Snapwell inserts, grown at an air–liquid interface, and placed in
a Ussing chamber system (Vertical Diffusion Chamber, Physio-
logical Instruments, San Diego, CA, USA). Measurements were
performed in the presence of a transepithelial Cl− gradient, in
which the basolateral side solution contained (in mmol/L): 130
NaCl, 2.7 KCl, 1.5 KH2PO4, 1 CaCl2, 0.5 MgCl2, 10 Na–HEPES,
pH 7.3, and 10 glucose; The apical side solution contained the
same components except that 65mmol/L NaCl was replaced by
sodium gluconate and the concentration of CaCl2 was increased
to 2mmol/L. The basolateral membrane was permeabilized with
250μg/ml amphotericin B (He et al., 2005).
For measurements of transepithelial Cl− current on rat colonic
mucosa, rat colonic mucosa was obtained as described previ-
ously (He et al., 2005). Brieﬂy, SD rats (weight about 200 g) were
starved for 24 h prior. Segments of colon were excised after the
rat was sacriﬁced with intravenous pentobarbital (100mg/kg).
The colon was immediately stripped of muscularis, mounted in
Ussing chambers (area 1.03 cm2), and bathed in Krebs–Henseleit
(KH) solution (inmmol/L:NaCl 117,KCl 4.7,MgCl2 1.2,KH2PO4
1.2, NaHCO3 24.8, CaCl2 2.5, glucose 11.1, pH 7.4). Short-
circuit current was measured after inhibition of Na+ current by
amiloride (10μmol/L) and prostaglandin generation inhibitor of
indomethacin (10μmol/L), followed by stimulation by forskolin
(20μmol/L) and subsequent inhibitor addition (Ma et al., 2002).
All in vivo studies including isolation of rat colonic mucosa and
mouse trachea followed guidelines for animal experiments in Jilin
University.
Measurementswereperformedat 37˚C,and solutionswere con-
tinuously bubbled with air. Short-Circuit current was recorded
with a DVC-1000 voltage clamp (World Precision Instruments,
Sarasota, FL, USA) via Ag/AgCl electrodes and 1mol/L KCl agar
bridges.
MEASUREMENT OF INDIVIDUAL SUBMUCOSAL GLAND FLUID
SECRETION
Freshly excised the most cranial part of mouse trachea was imme-
diately mounted on a sponge. The system was soaked in KH solu-
tion and held in a perfusion chamber with the mucosal side up in
a humidiﬁed 5% CO2/95% air atmosphere at 37˚C during tests as
described previously (Song andVerkman, 2001). After the mucosa
was clearedwith saline and dried by nitrogen stream, 200μL saline
saturated oil was added to the surface. In some experiments the tis-
sueswere incubated for 30min inKHbuffer containing 20μmol/L
CFTRinh-172. Gland ﬂuid droplets were imaged and recorded
by a reﬂected light microscopy (Olympus, Olympus Micro DP
Controller) after stimulation with compounds. The rate of ﬂuid
secretion from individual submucosal gland was computed from
ﬂuid droplet diameter assuming semi-spherical droplet geometry
as reference (Song and Verkman, 2001).
STATISTICAL ANALYSIS
Data are reported as means± SE. Statistical signiﬁcance of the
effects was determined by using the OriginPro 8.0 software.
RESULTS
Initial experiments were preformed to verify activation of wt-
CFTR by ﬁve coumarin ΔF508-CFTR potentiators we identi-
ﬁed previously (Xu et al., 2008). The ﬁve coumarins (structures
shown in Figure 1A) stimulated wt-CFTR-mediated I− inﬂux
in a concentration-dependent way, with an afﬁnity sequence
from higher to lower as: osthole> scoparone> imperatorin>
isopsoralen> praeruptorin A (Figure 1B). The potency and efﬁ-
cacy of osthole aremuch higher than the knownCFTR potentiator
genistein.
CFTR activation potencies of coumarins were further ana-
lyzed on the more reliable short-circuit current assay. Mea-
surements were performed after the basolateral membrane of
FRT cells were permeabilized with amphotericin B and in the
presence of transepithelial Cl− gradient. As the representative
curves shown in Figure 2A and summarized in Figure 2B, the
three potent coumarin activators identiﬁed in the ﬂuorescent
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assay stimulated transepithelial Cl− current in the presence of
0.1μmol/L FSK. Noticeably, osthole exhibited very high afﬁnity
(with K d< 50 nmol/L). The CFTR speciﬁc blocker CFTRinh-172
at 20μmol/L completely blocked the activations. These data indi-
cated that the coumarin compounds stimulated Cl− currents
through CFTR.
Osthole was used to further evaluate the potential effects of
coumarin compounds on CFTR-mediated Cl− secretion in live
tissues. The ﬁrst set of experiments was performed in strips of
FIGURE 1 | Functional analysis of natural coumarin compounds in FRT
cells expressing wild-type CFTR. (A) Chemical structures of the active
coumarins. (B) Concentration–response curves for the active coumarins.
Assays were performed in the presence of 0.1μmol/L forskolin. Genistein
was used as a positive control. (mean±SE, n=4).
rat distal colonic mucosa by short-circuit current assays. Ost-
hole was applied on mucosal (Figure 3A) and serosal (Figure 3B)
sides separately. Maximal stimulations were obtained at osthole
concentration of 5μmol/L. CFTRinh-172 completely abolished
the osthole-stimulated chloride secretion. Quantiﬁed effects of
osthole on rat colonic mucosa Cl− secretion were shown in
Figure 3C.
Another set of experiments was performed in freshly excised
fragments of the cranial portion of mouse trachea. The effect
of osthole on the rates of ﬂuid secretion from airway submu-
cosal glands was measured from the growth of individual ﬂuid
droplets visualized by low-magniﬁcation light microscopy. Gland
ﬂuid secretion was stimulated by addition of 10μmol/L pilo-
carpine or 10μmol/L osthole to the serosal bathing solution.
Figure 4A shows a series of images of expanding ﬂuid droplets
secreted by single submucosal glands after stimulation by osthole,
with pilocarpine as positive control. Figure 4B summarizes the
ﬂuid secretion rate of individual submucosal gland stimulated by
the indicated maneuvers. Osthole increased ﬂuid secretion rate by
3.34-fold compared to the saline control. The effect was largely
abolished by CFTRinh-172.
DISCUSSION
In a previous study, we identiﬁed a family of natural coumarin
compounds (including osthole, scoparone, imperatorin, praerup-
torin A, and isopsoralen) that can rescue defective ΔF508-CFTR
chloride channel gating (Xu et al., 2008). The present study was
designed to determine the activity of these coumarin compounds
on CFTR activity in animal tissues as a primary evaluation of their
therapeutic potential.
We ﬁrst conﬁrmed the activity of the ﬁve coumarin ΔF508-
CFTR potentiators on wt-CFTR and identiﬁed osthole as a low
nonamolar afﬁnity activator (K d< 50 nmol/L). To our knowl-
edge, osthole may be the most potent natural CFTR activator
identiﬁed so far. However, the afﬁnity of osthole in potentiating
FIGURE 2 | Short-circuit current analysis of the natural coumarins in FRT
cells expressing wild-type CFTR. (A) Representative tracings of
wt-CFTR-mediated apical membrane Cl− currents are shown. Measurements
were performed after the basolateral membrane of Fischer rat thyroid (FRT)
cells had been permeabilized with 250mg/mL amphotericin B and in the
presence of a 60-mmol/L basolateral to apical transepithelial Cl− gradient.
Where indicated, various concentrations of the compounds were added to the
apical chamber solutions. (B) Dose–response analysis indicates that the
natural coumarins stimulated Cl− currents in a concentration-dependent
manner. (mean±SE, n=6).
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FIGURE 3 | Stimulation of mucosal Cl− current of rat colon
by osthole. Osthole-stimulated transepithelial Cl− current was
measured after inhibition of Na+ current by amiloride (10μmol/L)
and prostaglandin production by indomethacin (10μmol/L).
Where indicated, osthole and CFTRinh-172 was added. Osthole
was added to mucosal (A) and serosal (B) sides separately. (C)
Summary of mucosal Cl− current stimulated by osthole.
(mean±SE, n=6).
FIGURE 4 | Stimulation of submucosal glands fluid secretion of mouse
trachea by osthole. (A) Bright ﬁeld micrographs of expanding ﬂuid
droplets secreted from single submucosal glands. a, saline; b, osthole; c,
osthole plus CFTRinh-172; d, pilocarpine; e, pilocarpine plus CFTRinh-172. (B)
Linear volume increase of gland droplets (mean±SE, n=12) with time
after stimulation.
ΔF508-CFTR (∼10μmol/L; Xu et al., 2008) is >200-fold lower
than in activating wt-CFTR. The altered gating mechanism of
ΔF508-CFTR may be further investigated using osthole as a
probe.
The effect of coumarin compounds on CFTR-mediated ﬂuid
secretion in live tissues was demonstrated in two models. In the
ﬁrst model, osthole-stimulated signiﬁcant Cl− secretion in freshly
isolated rat colonic mucosa with maximal effect at 5μmol/L
in Ussing chamber short-circuit current assay. The effect is
fully reversed by CFTRinh-172. In the second model, osthole
at 10μmol/L stimulated ∼3-fold more rapid ﬂuid secretion by
tracheal single submucosal gland than that in the control. The
stimulated secretions were also fully abolished by CFTRinh-172.
These results clearly indicated that coumarin compound osthole
can effectively stimulate CFTRCl− transport and ﬂuid secretion in
live epithelial tissues and the effect is through activation of CFTR
chloride channel.
The mechanisms of CFTR activation by coumarin compounds
remainunclear.CFTRactivation involves several indirect pathways
and direct interactions (Hwang and Sheppard, 1999; Schultz et al.,
1999). Because coumarins modulate many intracellular pathways
(Wu et al., 2009), its activity in activating CFTR may involve both
direct and indirect interactions with the CFTR protein. Our pre-
vious studies suggested that coumarin compounds may activate
wild-type and ΔF508-CFTR chloride channel activity by a direct
interaction with CFTR protein (Ma et al., 2002; Xu et al., 2008),
but precise molecular mechanisms need to be fully characterized
by systematic electrophysiological studies.
In conclusion, we have demonstrated for the ﬁrst time that nat-
ural coumarin compound osthole can effectively stimulate CFTR-
mediated Cl– secretion in colonic mucosa and ﬂuid secretion in
tracheal submucosal glands. The results suggested the therapeutic
potential of natural coumarin compounds for the treatment of CF
and other CFTR-related diseases.
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